Trial
NCT01188889
RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Michigan Rogel Cancer Center
Collaborators
Novartis
Condition
Chronic Myeloid Leukemia
Intervention
RAD001
Why stopped
Unable to obtain sufficient funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-05-15